CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.59
+1.37%Margins
Gross margin
86.9%
EBITDA margin
47.6%
EBIT margin
40.9%
Net margin
47.6%
FCF margin
0.0%
39.7%
Return on equity
25.4%
Return on assets
33.0%
Return on invested capital
0.52x
Asset turnover
$0.00
Cash from operations
$1.32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026